If you have been visiting Health Impact News, you may have noticed the notion that arterial inflammation is what’s behind heart disease, not cholesterol from saturated fats.
A clinical human trial recently published in The New England Journal of Medicine in August of 2017 may tip a few more in the medical field into accepting the current awareness that inflammatory damage is a major cause of heart and cardiovascular disease, and cholesterol is trying to patch up the damage before the vessel begins to leak or rupture.
Cholesterol is actually a vitally useful “waxy” compound for many parts of our bodies, especially the brain. Lowering cholesterol is misguided, and usually causes terrible side effects.
Upon releasing the study and after its publication, the lead researcher Dr. Paul Ridker, MD, asserted:
"These findings represent the end game of more than two decades of research, stemming from a critical observation: Half of heart attacks occur in people who do not have high cholesterol. For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk."
